10% Owner of Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), Innoviva, Inc., buys 6,268,975 shares worth $12,537,950
According to Entasis Therapeutics Holdings Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 11 05:39 PM, company 10% Owner, Innoviva, Inc. disclosed buying 6,268,975 shares at a cost of $2.00. At the time of this transaction (Jun 11), this trade was worth $12,537,950 in total. As of Jun 11, Innoviva, Inc. now owns 10,000,000 shares in total worth about $28,400,000.0.
For the last few recent trades made by Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) 10% Owner, Innoviva, Inc., we have the following information:
- SEC Form 4 filing: May 03: Bought 3,731,025 shares at the rate of $2.00 per share. Total worth of this trade was $7,462,050. Total number of shares owned as of May 03 were 3,731,025
- SEC Form 4 filing: Sep 01: Bought 4,672,897 shares at the rate of $2.67 per share. Total worth of this trade was $12,499,999. Total number of shares owned as of Sep 01 were 18,672,897
- SEC Form 4 filing: Jun 11: Bought 12,677,490 shares at the rate of $2.50 per share. Total worth of this trade was $31,693,725. Total number of shares owned as of Jun 11 were 14,000,000
Posted by
George Daniels
on Monday June 14 2021, 11:34 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
